SEARCH

SEARCH BY CITATION

References

  • 1
    Raoof N, Sharrack B, Pepper IM, Hickman SJ. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 2011;18:1266-1268.
  • 2
    Wall M. Idiopathic intracranial hypertension and the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol. 2013;33:1-3.
  • 3
    Friedman DI, Liu G, Digre KB. Diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159-1165.
  • 4
    Avery RA, Shah SS, Licht DJ, et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010;363:891-893.
  • 5
    Butros SR, Goncalves LF, Thompson D, Agarwal A, Lee HK. Imaging features of idiopathic intracranial hypertension, including a new finding: Widening of the foramen of ovale. Acta Radiol. 2012;53:682-688.
  • 6
    Johnston I , Owler B , Pickard J eds. The Pseudotumor Cerebri Syndrome. Cambridge, UK.: Cambridge University Press; 2007.
  • 7
    Passot R. Meningites et etats meninges aseptiques d'origine otique. In: These de Paris. Paris: G. Steinheil; 1913. no. 247.
  • 8
    Hughlings Jackson J. Discussion on the relationship between optic neuritis and intracranial disease. Trans Ophthalmol Soc UK. 1880;1:60-115.
  • 9
    Nonne M. Der pseudotumor cerebri. Neue Deutsche Chirurgie. 1914:107-152.
  • 10
    Quincke H. Meningitis serosa. Sammi Klin Vortr., Leipzig, No. 67. Inn Med. 1893;23:655.
  • 11
    Symonds CP. Otic hydrocephalus. Brain. 1931;54:55-71.
  • 12
    Davidoff LM, Dyke CG. Hypertensive meningeal hydrops. Am J Ophthalmol. 1937;20:908-927.
  • 13
    Dandy WE. Intracranial pressure without brain tumor: Diagnosis and treatment. Ann Surg. 1937;106:492-513.
  • 14
    Foley J. Benign forms of intracranial hypertension. Toxic and otitic hydrocephalus. Brain. 1955;78:1-41.
  • 15
    Milhorat TH. Physiology of the cerebrospinal fluid. In: Milhorat TH , ed. Cerebrospinal Fluid and Brain Edemas. New York: Neuroscience Society of New York; 1987:39-73.
  • 16
    Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS. Atrial natriuretic peptide: Its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochir Suppl. 2006;96:451-456.
  • 17
    Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J. The choroid plexus-cerebrospinal fluid system: From development to aging. Curr Top Dev Biol. 2005;71:1-52.
  • 18
    Maren TH. The kinetics of HCO3- synthesis related to fluid secretion, pH control, and CO2 elimination. Annu Rev Physiol. 1998;50:695-717.
  • 19
    Tripathi BJ, Tripathi RC. Vacuolar transcellular channel as a drainage pathway for cerebrospinal fluid. J Physiol. 1974;239:195-206.
  • 20
    Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009;117:1-14.
  • 21
    Johnson M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels of humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res. 2004;1:1-13.
  • 22
    Edsbagge M, Tisell M, Jacobsson L, Wikkelso C. Spinal CSF absorption in healthy individuals. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1450-R1455.
  • 23
    Benga O, Huber VJ. Brain water channel proteins in health and disease. Mol Aspects Med. 2012;33:562-578.
  • 24
    Tanimura Y, Hiroaki Y, Fujiyoshi Y. Acetazolamide reversibly inhibits water conduction by aquaporin-4. J Struct Biol. 2009;166:16-21.
  • 25
    Ameil PA, Madan M, Chigurupati S, Yu A, Chan SL, Pattisapu JV. Effect of acetazolamide on aquaporin-1 and fluid flow in cultured choroid plexus. Acta Neurochir Suppl. 2012;113:59-64.
  • 26
    Huber VJ, Tsujita M, Kwee IL, Nakada T. Inhibition of aquaporin 4 by antiepileptic drugs. Bioorg Med Chem. 2009;17:418-424.
  • 27
    Kerty E, Heuser K, Indahl UG, et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol. 2013;91:88-91.
  • 28
    Sklar FH, Reisch J, Elashvili I, Smith T, Long DM. Effects of pressure on cerebrospinal fluid formation: Non steady-state measurements in dogs. Am J Physiol. 1980;R277-R284.
  • 29
    Welch K. The principles of physiology of the cerebrospinal fluid in relation to hydrocephalus including normal pressure hydrocephalus. Adv Neurol. 1975;13:247-332.
  • 30
    Sahar A. The effect of pressure on the production of cerebrospinal fluid by the chorioid plexus. J Neurol Sci. 1972;26:49-58.
  • 31
    Donaldson JO. Cerebrospinal fluid hypersecretion in pseudotumor cerebri. Trans Am Neurol Assoc. 1979;104:196-198.
  • 32
    Johnson IH, Paterson A. Benign intracranial hypertension. II CSF pressure and circulation. Brain. 1974;97:301-312.
  • 33
    Mann JD, Johnson RN, Butler AB, Bass NH. Cerebrospinal fluid circulatory dynamics in pseudotumor cerebri and response to steroid treatment. Neurology. 1979;29:550.
  • 34
    Gjerris P, Sorensen PS, Vorstrup S, Paulson OB. Intracranial pressure, conductance to CSF outflow and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol. 1985;17:158-162.
  • 35
    Janny P, Chazal J, Colnet G, Irthum B, George AM. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol. 1981;15:168-174.
  • 36
    Alperin N, Ranganathan S, Bagci AM, et al. MRI evidence of impaired CSF homeostasis in obesity-associated idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2013;34:29-34.
  • 37
    Alperin N, Lam BL, Tain RW, et al. Evidence for altered spinal canal compliance and cerebral venous drainage in untreated idiopathic intracranial hypertension. Acta Neurochir Suppl. 2012;114:201-205.
  • 38
    Owler BK, Parker G, Halmagyi GM,et al. Cerebral venous outflow obstruction and pseudotumor cerebri syndrome. Adv Tech Stand Neurosurg. 2005;30:108-178.
  • 39
    King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995;45:2224-2228.
  • 40
    King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology. 2002;58:26-30.
  • 41
    Higgins JN, Pickard JD. Letter in reply to King et al. Neurology. 2002;59:963-964.
  • 42
    Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis. Neurology. 2003;60:1418-1424.
  • 43
    Alper F, Kantarci M, Dane S, et al. Importance of anatomical asymmetries of transverse sinuses: An MR venographic study. Cerebrovasc Dis. 2004;18:236-239.
  • 44
    Roche J, Warner D. Arachnoid granulations in the transverse and sigmoid sinuses: CT, MR, and MR angiographic appearances of a normal anatomic variation. Am J Neuroradiol. 1996;17:677-683.
  • 45
    Arjona A, Delgado F, Fernandez-Romero E. Intracranial hypertension secondary to giant arachnoid granulations. J Neurol Neurosurg Psychiatry. 2003;74:418.
  • 46
    Bedford THB. The effect of increased intracranial venous pressure in the pressure of the cerebrospinal fluid. Brain. 1935;58:427-447.
  • 47
    Bateman GA. Idiopathic intracranial hypertension: Priapism of the brain? Med Hypotheses. 2004;63:549-552.
  • 48
    Rohr A, Bindeballe J, Riedel C, et al. The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: A longitudinal volumetric magnetic resonance imaging study. Neuroradiology. 2012;54:25-33.
  • 49
    Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol. 2011;31:374-380.
  • 50
    Dwyer CM, Prelog K, Owler BK. The role of venous sinus outflow obstruction in pediatric idiopathic intracranial hypertension. J Neurosurg Pediatr. 2013;11:144-149.
  • 51
    Koerner J, Friedman DI. Inpatient and emergency service utilization in patients with idiopathic intracranial hypertension. J Neuroophthalmol. In Press.
  • 52
    Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology. 2006;67:419-423.
  • 53
    Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol. 2008;255:807-812.
  • 54
    Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49:185-193.
  • 55
    Neville L, Egan RA. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol. 2005;40:775-777.
  • 56
    Benzer A, Gottardis M, Russegger L, Langmayr J, Balogh D. Fentanyl increases cerebrospinal fluid pressure in normocapnic volunteers. Eur J Anaesthesiol. 1992;9:473-477.
  • 57
    Glueck CJ, Aregawi D, Goldberg N, et al. Idiopathic intracranial hypertension, polycystic ovary syndrome, and thrombophilia. J Lab Clin Med. 2005;145:72-82.
  • 58
    Bowles LK, Cooper JA, Howarth DJ, Miller GJ, MacCallum PK. Associations of haemostatic variables with body mass index: A community-based study. Blood Coagul Fibrinolysis. 2003;14:569-573.
  • 59
    Kesler A, Yatziv Y, Shapira I, Berliner S, Assayag EB. Increased red blood cell aggregation in patients with idiopathic intracranial hypertension. A hitherto unexplored pathophysiological pathway. Thromb Haemost. 2006;96:483-487.
  • 60
    Weber KT. Aldersteronism revisited: Perspectives on less well-recognized actions of aldosterone. J Lab Clin Med. 2003;142:71-82.
  • 61
    Weber KT, Singh KD, Hey JC. Idiopathic intracranial hypertension with primary hyperaldosteronism. Report of two cases. Am J Med Sci. 2002;324:45-50.
  • 62
    Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg. 1964;107:159-172.
  • 63
    Kageyama Y, Suzuki H, Saruta T. Presence of aldeosterone-like immunoreactivity in cerebrospinal fluid in normotensive subjects. Acta Endocrinol (Copenh). 1992;126:501-504.
  • 64
    Cascella T, Palomba S, Tauchmanovà L, et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2006;91:4395-4400.
  • 65
    Armani D, Bordin L, Donà G, et al. Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids. 2012;77:655-658.
  • 66
    Friedman DI, Streeten DHP. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology. 1998;50:1099-1104.
  • 67
    Streeten DHP, Dalakos TG, Souma M, et al. Studies of the pathogenesis of idiopathic oedema. Clin Sci Mol Med. 1973;45:347-373.
  • 68
    Seckl J, Lightman S. Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1988;51:1538-1541.
  • 69
    Seckl JR, Lightman SL. Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats. Brain Res. 1987;423:279-285.
  • 70
    Sørensen PS. Studies of vasopressin in human cerebrospinal fluid. Acta Neurol Scand. 1986;74:81-102.
  • 71
    Skau M, Goetze JP, Rehfeld JF, Jensen R. Natriuretic pro-peptides in idiopathic intracranial hypertension. Reg Pept. 2010;164:71-77.
  • 72
    Sugarman HJ, DeMaria EJ, Felton WL, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997;49:507-511.
  • 73
    Schwartz KM, Luetmer PH, Hunt CH, et al. Position-related variability of CSF opening pressure measurements. Am J Neuroradiol. 2013;34:904-907.
  • 74
    Abel AA, Brace JR, McKinney AM, et al. Comparison of cerebrospinal fluid opening pressure in the prone and lateral decubitus positions. J Neuroopthalmol. In Press.
  • 75
    Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology. 1984;34:721-729.
  • 76
    Whiteley W, Al-Shahi R, Warlow CP, Zeidler M, Lueck CJ. CSF opening pressure: Reference interval and the effect of body mass index. Neurology. 2006;67:1690-1691.
  • 77
    Bono F, Lupo MR, Serra P, et al. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology. 2002;59:1641-1643.
  • 78
    Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension: A preliminary case-control study. Arch Neurol. 1990;47:315-320.
  • 79
    Guiseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology. 1991;41:239-244.
  • 80
    Radhakrishnan K, Thaker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: A prospective and case-control study. J Neurol Sci. 1993;116:18-28.
  • 81
    Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: A case control study. Neurology. 2011;76:1564-1567.
  • 82
    Hannerz J, Greitz D, Ericson K. Is there a relationship between obesity and intracranial hypertension? Int J Obes Relat Metab Disord. 1995;19:240-244.
  • 83
    Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428-432.
  • 84
    Mendelson CR, Simpson ER. Regulation of estrogen biosynthesis by human adipose cells in vitro. Mol Cell Endocrinol. 1987;52:169-176.
  • 85
    Misso ML, Jang C, Adams J, et al. Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause. 2005;12:210-215.
  • 86
    Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA. 2003;100:14211-14216.
  • 87
    Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72:304-309.
  • 88
    Fraser JA, Bruce BB, Rucker J, et al. Risk factors for idiopathic intracranial hypertension in men: A case-control study. J Neurol Sci. 2010;290:86-89.
  • 89
    Thurtell MJ, Trotti LM, Bixler EO, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: Comparison with matched population data. J Neurol. 2013;260:1748-1751.
  • 90
    Smeland S, Bjerknes T, Malaba L, et al. Tissue distribution of the receptor for plasma retinol-binding protein. Biochem J. 1995;305:419-424.
  • 91
    MacDonald PN, Bok D, Ong DE. Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human. Proc Natl Acad Sci USA. 1990;87:4265-4269.
  • 92
    Morrice G Jr, Havener WH, Kapetansky F. Vitamin a intoxication as a cause of pseudotumor cerebri. JAMA. 1960;173:1802-1805.
  • 93
    Selhorst JB, Waybright EA, Jennings S, Corbett JJ. Liver lover's headache, pseudotumor cerebri and vitamin A intoxication. JAMA. 1984;252:3364.
  • 94
    de Veer G. From ‘a true description of three voyages by the north-east towards Cathay and China. In: Charles T , ed. Beke. New York: Cambridge University Press; 1853. Reprinted 2009.
  • 95
    Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29-37.
  • 96
    Millen JW, Woollam DHM. Vitamins and the cerebrospinal fluid. In: Wolstenholme GEW , O'Connor CMJ , A Churchill Ltd, eds. The CIBA Foundation Symposium on the Cerebrospinal Fluid. London: Novartis Foundation Symposium; 1958:168-188.
  • 97
    Panozzo G, Babighian S, Bonora A. Association of xerophthalmia, flecked retina, and pseudotumor cerebri caused by hypovitaminosis A. Am J Ophthalmol. 1998;125:708-710.
  • 98
    Calhoun MC, Hurt HD, Eaton HD, Rousseau JE Jr, Hall RC Jr. Rates of formation an absorption of cerebrospinal fluid in bovine hypovitaminosis A. J Dairy Sci. 1967;50:1489-1494.
  • 99
    Hayes KC, McCombs HL, Faherty TP, et al. The fine structure of vitamin A deficiency. II Arachnoid granulations and CSF pressure. Brain. 1971;94:213-224.
  • 100
    Kushida A, Tamura H. Retinoic acids induce neurosteroid biosynthesis in human glial Gl-1 cells via the induction of steroidogenic genes. J Biochem. 2009;146:917-923.
  • 101
    Baker ME, Funder JW, Kattoula SR. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors. J Steroid Biochem Mol Biol. 2013;137:57-70.
  • 102
    Jacobson DM, Berg R, Wall M, et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology. 1999;53:1114-1118.
  • 103
    Warner JE, Bernstein PS, Yemelyanov A, et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol. 2002;52:647-650.
  • 104
    Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol. 2007;258-262.
  • 105
    Frey SK, Vogel S. Vitamin A metabolism and adipose tissue biology. Nutrients. 2011;3:27-29.
  • 106
    Braunhut SJ, Palomares M. Modulation of endothelial cell shape and growth by retinoids. Microvasc Res. 1991;41:47-62.
  • 107
    Fainaru O, Adini I, Benny O, et al. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J. 2008;22:3728-3735.
  • 108
    Walsh FB. Papilloedema associated with increased intracranial pressure in Addison's disease. Arch Ophthalmol. 1952;47:86.
  • 109
    Laurence BM, Matthews WB, Shephard RH. Raised intracranial pressure associated with triamcinolone. Lancet. 1960;2:701-702.
  • 110
    Zada G, Tirosh A, Kaiser UB, Woodmansee WW. Cushing's disease and idiopathic intracranial hypertension: Case report and review of underlying pathophysiological mechanisms. J Clin Endocrinol Metab. 2010;95:4850-4854.
  • 111
    Johnston I. The pseudotumor syndrome. MD thesis, 1992;University of Dundee, UK.
  • 112
    Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol. 1994;117:352-357.
  • 113
    Sato O, Hara M, Asai T, Tsugane R, Kageyama N. The effect of dexamethasone phosphate on the production rate of CSF in the spinal subarachnoid space of dogs. J Neurosurg. 1973;39:480-484.
  • 114
    Pollay M. Pharmacological manipulation of cerebrospinal fluid secretion. In: Segal MB , ed. Barriers and Fluids of the Eye and Brain. London: Macmillan Press; 1992:49-58.
  • 115
    Johnston I, Gilday DL, Hendrick EB. The effects of steroids and steroid withdrawal on CSF absorption. An experimental study in dogs. J Neurosurg. 1975;42:690-695.
  • 116
    Lindvall-Axelsson M, Owman C. Actions of sex steroids and corticosteroids on rabbit choroid plexus as shown by changes in transport capacity and rate of cerebrospinal fluid formation. Neurol Res. 1990;12:181-186.
  • 117
    Gorodeski GI. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occluding. Endocrinology. 2007;148:218-231.
  • 118
    Greer M. Benign intracranial hypertension (pseudotumor cerebri). In: Vinken PJ , de Bruyn GW , eds. Handbook of Clinical Neurology. Amsterdam: Elsevier; 1974:150-166.
  • 119
    Wall M, Dollar JD, Sadun AA, Kardon R. Idiopathic intracranial hypertension. Lack of histological evidence for cerebral edema. Arch Neurol. 1995;52:141-145.
  • 120
    Weisberg LA. Computed tomography in benign intracranial hypertension. Neurology. 1985;35:1075-1078.
  • 121
    Carreras FL, Lehmann GL, Ferri D, Tioni MF, Calamita G, Marinelli RA. Defective hepatocyte aquaporin-8 expression and reduced canalicular membrane water permeability in estrogen-induced cholestasis. Am J Physiol Gastrointest Liver Physiol. 2007;292:G905-G912.